Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

eVestment HFN: Securitized credit funds returned +13.73% YTD versus +4.94% for the hedge fund aggregate

Tuesday, October 09, 2012
Opalesque Industry Update: eVestment|HFN today announced that securitized credit funds are among the hedge fund industry’s best performing sub classification in 2012, according to their latest sector focus report. Securitized credit funds returned +13.7 percent year-to-date (YTD) through September compared to +4.9 percent for the HFN Hedge Fund Aggregate Index.

Among securitized credit funds, the best performing sub-group YTD has been those investing specifically in asset-backed securities (ABS), up +14.5 percent. Only funds focused on India, and the healthcare sector have produced better average returns in 2012.

“From investor interest to performance, the securitized credit hedge fund universe has been one of the highlights of the entire hedge fund industry since the financial crisis. In that time frame, mortgage backed securities (MBS) yields have fallen to record lows and some $19.6 billion has been directed to mortgage related strategies alone.” said Peter Laurelli, Vice President, Research, eVestment|HFN. ”Looking at the massive amounts allocated to all credit related strategies in general over the last year, both on the hedge fund and traditional asset management side, there is a lot of money chasing rapidly declining yields and tightening spreads across the credit universe.”

The report found that assets targeting securitized credit reached another all-time high at the end of August, its fourth consecutive quarterly peak. eVestment estimates total hedge fund assets investing in securitized credit markets reached $119.4 billion at the end of August 2012, $72.3 billion of which is focused primarily on MBS. Total assets under management (AUM) in ABS/mortgage focused strategies are estimated to be $72.3 billion at the end of August 2012. This is an increase of 14.6 percent in 2012, which is well above the industry average AUM increase of 4.0 percent.

Securitized credit funds continue to show higher volatility relative to other fixed income strategies. Historical volatility as measured by annualized standard deviation for MBS centric strategies were 10.1 percent, followed by 12.5 percent for ABS focused strategies, and 13.7 percent for collateralized debt obligations (CDO) only strategies; this compares to an average of 8.6 percent for all fixed income funds.

“Volatility is not necessarily a bad thing, in this case the elevated level is mostly ‘upside volatility’ from periods of higher than normal positive returns,” said Mr. Laurelli.

The report contains comparisons across a variety of securitized credit regional and sub-classifications, including across funds targeting distressed securitized assets and those targeting products originated from European credits.

Mr. Laurelli adds, “Funds targeting securitized products originated with European assets were the only sub-classification to show negative performance in 2011, which shows that in an elevated risk environment; generally well performing and low correlated assets can still result in losses.”

The entirety of Europe securitized credit losses in 2011 came during the second half of the year and the group fell an average of 4.9 percent. The report notes the group has rebounded in 2012, +12.7 percent.

eVestment

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its